AUSTRALIA MEDTECH PITCH DECK AGENCY
The MedTech Pitch Deck Design Agency Australia That Gets TGA Cleared Devices Investor Funded
Australian Medical Device Decks Built for Capital
Australia produced two of the world's most significant medical device innovations, Cochlear's implant and ResMed's CPAP device, establishing Australian medtech as a credible global innovation source. The TGA is widely regarded as one of the world's most rigorous device regulators. Active investors include Brandon Capital, MTPConnect, and Cochlear Ventures.
Australian medtech founders often have TGA-cleared or ARTG-listed devices, NHMRC research validation, and clinical trial data from Australian hospitals, but struggle to present these strengths in a format Brandon Capital MRCF committees and strategic medtech corporate teams can evaluate efficiently. Relevant sub-sectors include hearing technology, sleep and respiratory monitoring, point-of-care diagnostics, digital pathology hardware, wearable aged care monitoring, and surgical tools.
Slidey is the MedTech pitch deck design agency Australia founders trust to understand regulatory pathways and commercial narratives. Slidey works with founders across hearing tech, diagnostics, wearable monitors, surgical tools, and aged care devices raising seed through Series A.
.png)
Translating TGA Pathways Into Australian Medtech Investment Milestones
Slidey converts TGA conformity assessment, ARTG inclusion, and ISO 13485 into investable milestone slides, framing each as a valuation gate, core to any MedTech startup pitch deck consultants Australia engagement.
Slidey builds MBS item number application, MSAC health technology assessment, private health insurance coverage, and prostheses list listing for implantable devices into investor-grade commercial market access proof.
WHY CHOOSE OUR MEDTECH PITCH DECK DESIGN SERVICE AUSTRALIA
Slidey designs decks with a genuine understanding of TGA pathways, ARTG milestones, and how Brandon Capital, Artesian Capital, and Cochlear Ventures evaluate opportunities.
Cochlear and ResMed heritage positions Australia as a credible origin. Our MedTech pitch deck design service Australia leverages this as a confidence signal.
.png)
Australian MedTech Founders Funded Through Regulatory Clarity
Australia's medtech investment community, Brandon Capital managing the MRCF, MTPConnect, Artesian Capital, Cochlear Ventures, and strategics including Stryker, Medtronic, and Abbott, evaluates decks against five dimensions: TGA regulatory credibility, clinical evidence quality, MBS reimbursement strategy, IP defensibility, and acquisition exit potential. As MedTech pitch deck experts Australia founders rely on, Slidey knows founders with TGA-cleared devices still lose rounds when decks fail to present all five coherently. Results below are actual raises.
Our Australian MedTech Pitch Deck Design Process
Australian MedTech Discovery
We learn the device type, TGA stage, ARTG status, grant funding, trial data, and target investor.
TGA Pathway Mapping
We map conformity assessment route, ARTG milestones, and ISO 13485 staging into a capital deployment timeline.
Clinical and Heritage Evidence Architecture
We build evidence using NHMRC validation and Australian trial data, framed within the country's device heritage.
Reimbursement and Commercial Strategy
We build MBS, MSAC, and prostheses list strategy, plus the acquisition exit thesis for strategic buyers.
Visual Design Build
We design clinical-grade visuals, TGA timelines, trial outcome charts, and competitive landscape matrices for investment committees.
Final Investor Delivery
We deliver the finished deck in all formats, ready for Brandon Capital, Cochlear Ventures, and strategic investor meetings.
Purposeful Pricing for Every Australian MedTech Fundraising Stage
For early-stage founders raising seed rounds from MTPConnect-connected investors and medtech angels funding TGA pathway initiation.
$800
Where Australian MedTech Founders Begin With Slidey
Funded Australian MedTech Decks That Reached Investment Committees
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)

.avif)

.avif)
.avif)
Our Pitch Deck Design Portfolio
frequently asked questions
Yes. Slidey's MedTech pitch deck design agency Australia team understands TGA conformity assessment, ARTG inclusion across device classes, clinical evidence requirements, MSAC and prostheses list processes, ISO 13485 certification, and NHMRC funding validation. Your deck reflects genuine Australian regulatory and commercialization knowledge.
Yes, but separately. Slidey maintains dedicated pages per sub-vertical: healthcare operators visit the Australian Healthcare page, biopharma visits the future Australian Biotech page, and digital health software visits the future Australian HealthTech page. This page serves physical medical devices, surgical tools, diagnostic hardware, and implants only.
Slidey reframes TGA and ARTG completion as commercial market access events, not compliance achievements. Each milestone becomes a valuation gate unlocking hospital procurement and insurance coverage. ARTG inclusion is positioned as Australia's equivalent of FDA 510k clearance, a credential Stryker and Medtronic recognize globally.
Brandon Capital Partners managing the MRCF, MTPConnect, Artesian Capital, Cochlear Ventures, and ResMed's venture programme, alongside strategic corporate teams at Stryker, Medtronic, Abbott, and Johnson and Johnson assessing Australian device innovation for acquisition or partnership.
Yes. As MedTech startup pitch deck consultants Australia founders use, Slidey positions Cochlear or ResMed-adjacent technology within an established, globally recognized innovation tradition, giving international investors immediate credibility context as a strategic positioning asset in the deck.
Standard delivery is 7 to 10 business days, with a 3 to 5 day rush track. As MedTech pitch deck experts Australia founders rely on, we work around Brandon Capital deadlines, MTPConnect submission windows, and Cochlear Ventures review cycles.
Yes, both. As Medical technology deck specialists Australia trusts, we write TGA narrative, clinical and heritage content, MBS framing, and exit narrative for Cochlear, ResMed, Stryker, and Medtronic audiences, alongside full visual design.
.avif)
.avif)
.avif)
.avif)





.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)

.avif)
.avif)


.avif)
.png)




.avif)

.avif)





